Subscribe to stay informed!
Malvern-based Annovis Bio recently reported positive clinical trial results for buntanetap, the biopharmaceutical company’s lead new drug candidate in Parkinson’s disease patients…
Malvern-based Annovis Bio plans to focus on patients who have the early form of Alzheimer’s disease in the future development of its experimental…
Berwyn-based Annovis Bio is delaying the release of the late-stage study results of its experimental Parkinson’s disease treatment, writes John George for…
Positive news about Berwyn-based Annovis Bio’s experimental Alzheimer’s disease therapy bumped the company’s stock up by 16 percent Monday during mid…
Annovis Bio, a Berwyn-based biotech company, has managed to raise $8.7 million to advance its experimental treatment for Parkinson’s and Alzheimer’s…
Annovis Bio, the pharmaceutical company in Berwyn working on potential treatments for neurological disorders such as Alzheimer’s and Parkinson’s diseases, has filed for…
Berwyn-based QR Pharma, the biopharmaceutical company developing treatments for a number of neurological disorders, including Alzheimer’s and Parkinson’s diseases, has raised $530…
Pennsylvania American Water and Coatesville
Pennsylvania American Water welcomed stakeholders from the Coatesville area last Thursday to celebrate the 25th anniversary of the company’s…
QR Pharma, Inc. of Berwyn is collaborating with The Rockefeller University to develop a treatment for Huntington’s disease.
The collaboration will focus on preclinical…
Before we send you to this site, please subscribe to our daily newsletter.
